Endometriosis

• 

  Subject Areas on Research

  • Abdominal wall endometriomas. 
  • Abundance and Localization of Progesterone Receptor Isoforms in Endometrium in Women With and Without Endometriosis and in Peritoneal and Ovarian Endometriotic Implants. 
  • Adolescent chronic pelvic pain. 
  • An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women. 
  • Antibodies to endometrial transferrin and alpha 2-Heremans Schmidt (HS) glycoprotein in patients with endometriosis. 
  • Assessment of Long-Term Bowel Symptoms After Segmental Resection of Deeply Infiltrating Endometriosis: A Matched Cohort Study. 
  • Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas. 
  • Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. 
  • Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. 
  • Bladder endometriosis: conservative management. 
  • Challenges to our understanding of endometriosis pain. 
  • Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. 
  • Criteria that indicate endometriosis is the cause of chronic pelvic pain. 
  • Criteria that indicate endometriosis is the cause of chronic pelvic pain. 
  • Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis. 
  • Diagnosis and surgical treatment of colonic endometriosis. 
  • Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation. 
  • Endometriosis in a spigelian hernia sac: an unexpected finding. 
  • Endometriosis of the liver containing mullerian adenosarcoma: case report. 
  • Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. 
  • Estrogen production and metabolism in endometriosis. 
  • Evidence of a genetic link between endometriosis and ovarian cancer. 
  • Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. 
  • In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis. 
  • In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist. 
  • Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis. 
  • Is prior uterine surgery a risk factor for adenomyosis? 
  • Laparoendoscopic single-site surgery for management of ovarian endometriomas. 
  • Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers. 
  • Macrophages and infertility: oviductal macrophages as potential mediators of infertility. 
  • Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. 
  • Malignant peritoneal mesothelioma in patients with endometriosis. 
  • More than menorrhagia: A review of the obstetric and gynaecological manifestations of von Willebrand disease 
  • More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders 
  • Nonparametric bayes shrinkage for assessing exposures to mixtures subject to limits of detection. 
  • Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. 
  • Pathogenesis of endometriosis. 
  • Peritoneal fluid cell populations in infertility patients. 
  • Peritoneal fluid prolactin in infertile women with endometriosis: lack of evidence of secretory activity by endometrial implants. 
  • Peritoneal macrophages and infertility: the association between cell number and pelvic pathology. 
  • Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. 
  • Reduced trypsin-binding capacity of alpha 2-macroglobulin in the peritoneal fluid of women with endometriosis: possible relevance to alterations in macrophase function. 
  • Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate. 
  • Reply to: Continuous or cyclic contraceptives for endometriosis: a question still without an answer. 
  • Reply to: Continuous versus cyclic oral contraceptives for endometriosis: any conclusive evidence? 
  • Risk factors for postoperative urinary retention after laparoscopic and robotic hysterectomy for benign indications. 
  • Robotic-assisted hysterectomy for the management of severe endometriosis: a retrospective review of short-term surgical outcomes. 
  • Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. 
  • Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. 
  • Sperm phagocytosis by human peritoneal macrophages: a possible cause of infertility in endometriosis. 
  • Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization. 
  • Surgical management of chronic lower abdominal and groin pain in high-performance athletes. 
  • The Impact of Endometriosis across the Lifespan of Women: Foreseeable Research and Therapeutic Prospects. 
  • The Impact of Endometriosis on the Health of Women. 
  • The effect of danazol in the treatment of chronic cystic mastitis. 
  • The nature of the intraperitoneal exudate associated with infertility: peritoneal fluid and serum lysozyme activity. 
  • The stimulus responsible for the peritoneal fluid inflammation observed in infertile women with endometriosis. 
  • Ureteral endometriosis in patients after total abdominal hysterectomy: presentation and diagnosis: a case series. 
  • Vesical endometriosis: report of two cases and review of the literature. 
  • WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Broach, Amy Nicole, Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Minimally Invasive Gynecologic Surgery
  • Eaton, Jennifer, Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Reproductive Endocrinology & Fertility
  • Landa, Alejandro, Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Harris & Smith OB-GYN
  • Moorman, Patricia Gripka, Professor in Family Medicine and Community Health, Duke Cancer Institute
  • Sobolewski, Craig Joseph, Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Minimally Invasive Gynecologic Surgery